The Economic Times

Dr Reddys Laboratories receives approval from Health Canada for its generic semaglutide injection

Dr Reddy's Laboratories has achieved a significant milestone. Health Canada has approved its generic semaglutide injection. This makes Dr Reddy's the first company to receive market authorization for this treatment in Canada. The approval covers 2 mg/pen and 4 mg/pen dosages. This development aims to increase access to affordable diabetes treatments for Canadian patients.